These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 9588233)
1. Helminth associated hypereosinophilia and tropical endomyocardial fibrosis (EMF) in Nigeria. Andy JJ; Ogunowo PO; Akpan NA; Odigwe CO; Ekanem IA; Esin RA Acta Trop; 1998 May; 69(2):127-40. PubMed ID: 9588233 [TBL] [Abstract][Full Text] [Related]
2. Aetiology of endomyocardial fibrosis (EMF). Andy JJ West Afr J Med; 2001; 20(3):199-207. PubMed ID: 11922151 [TBL] [Abstract][Full Text] [Related]
3. Systemic thromboembolism in endomyocardial fibrosis (EMF): clinical observations, aetio-pathogenesis and treatment. Andy JJ; Ekott JU; Ansa VO Afr J Med Med Sci; 2010 Sep; 39(3):207-13. PubMed ID: 21416790 [TBL] [Abstract][Full Text] [Related]
4. Relation of severe eosinophilia and microfilariasis to chronic African endomyocardial fibrosis. Andy JJ; Bishara FF; Soyinka OO Br Heart J; 1981 Jun; 45(6):672-80. PubMed ID: 7259917 [TBL] [Abstract][Full Text] [Related]
5. Endomyocardial fibrosis in Africa. Falase AO Postgrad Med J; 1983 Mar; 59(689):170-8. PubMed ID: 6844202 [TBL] [Abstract][Full Text] [Related]
6. [Endomyocardial fibrosis: report of 22 Congolese cases]. Kimbally-Kaky G; Ekoba J; Nkoua JL; Bouramoue C Ann Cardiol Angeiol (Paris); 2000 Aug; 49(5):287-95. PubMed ID: 12555512 [TBL] [Abstract][Full Text] [Related]
7. Relation between eosinophilia and endomyocardial disease. Olsen EG; Spry CJ Prog Cardiovasc Dis; 1985; 27(4):241-54. PubMed ID: 3880918 [No Abstract] [Full Text] [Related]
8. Helminthiasis, the hypereosinophilic syndrome and endomyocardial fibrosis: some observations and an hypothesis. Andy JJ Afr J Med Med Sci; 1983; 12(3-4):155-64. PubMed ID: 6326549 [TBL] [Abstract][Full Text] [Related]
9. A case report of a 40-year-old woman with endomyocardial fibrosis in a non-tropical area: from initial presentation to high urgent heart transplantation. Wagner G; Haumer M; Poelzl G; Wiedemann D; Kliegel A; Ullrich R; Gartlehner G; Zuckermann A; Müller L; Mayr H; Moertl D BMC Cardiovasc Disord; 2019 Dec; 19(1):302. PubMed ID: 31881943 [TBL] [Abstract][Full Text] [Related]
10. Poverty and eosinophilia are risk factors for endomyocardial fibrosis (EMF) in Uganda. Rutakingirwa M; Ziegler JL; Newton R; Freers J Trop Med Int Health; 1999 Mar; 4(3):229-35. PubMed ID: 10223220 [TBL] [Abstract][Full Text] [Related]
11. Surgical experience with thrombotic and fibrotic forms of non-tropical eosinophilic endomyocardial disease. Arvay A; Lengyel M; Mészáros R; Palik I Thorac Cardiovasc Surg; 1985 Oct; 33(5):314-6. PubMed ID: 2416089 [TBL] [Abstract][Full Text] [Related]
19. Epidemiology aspects of endomyocardial fibrosis. Hutt MS Postgrad Med J; 1983 Mar; 59(689):142-6. PubMed ID: 6844196 [TBL] [Abstract][Full Text] [Related]
20. Distribution of antibodies against Coxsackie B viruses, arboviruses and Toxoplasma gondii among patients with endomyocardial fibrosis (EMF) compared with normal subjects from EMF endemic and non-endemic zones of Nigeria. Ijaola O; Falase AO Afr J Med Med Sci; 1990 Jun; 19(2):93-103. PubMed ID: 2165348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]